- Home
- DNLI vs CALM Comparison
DNLI vs CALM Comparison
Compare DNLI & CALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | CALM |
|---|---|---|
| Founded | 2013 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DNLI | CALM |
|---|---|---|
| Price | $23.58 | $90.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $34.33 | ★ $92.00 |
| AVG Volume (30 Days) | ★ 1.7M | 941.1K |
| Earning Date | 05-06-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 11.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.63 |
| Revenue | N/A | ★ $2,911,632,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $408.85 | N/A |
| P/E Ratio | ★ N/A | $13.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.58 | $71.92 |
| 52 Week High | $27.30 | $117.45 |
Technical Indicators
Market Signals| Indicator | DNLI | CALM |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 68.35 |
| Support Level | $18.27 | $79.83 |
| Resistance Level | $27.30 | $95.57 |
| Average True Range (ATR) | 1.31 | 3.21 |
| MACD | -0.32 | 0.26 |
| Stochastic Oscillator | 30.43 | 96.82 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.